Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Apr 2020 07:30

RNS Number : 5304J
Circassia Pharmaceuticals Plc
14 April 2020
 

Director/PDMR Shareholding

Oxford, UK - 14 April 2020: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 9 April 2020, Ian Johnson, Executive Chairman of Circassia purchased 200,000 Ordinary Shares at a price of 22.85 pence per share, Michael Roller, Chief Financial Officer purchased 200,000 Ordinary Shares at a price of 22.683 pence per share and Jonathan Emms, Chief Operating Officer of Circassia, purchased 300,000 Ordinary Shares at a price of 23.2 pence per share.

Following these purchases, Ian Johnson holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company), Michael Roller holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company) and Jonathan Emms holds 600,000 Ordinary Shares (0.16% of the issued share capital of the Company).

Contacts

Circassia Pharmaceuticals plc

Ian Johnson Executive Chairman

Michael Roller Chief Financial Officer

c/o FTI Consulting

 

 

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel / Oliver Jackson

 

Tel: +44 (0)20 7418 8900

finnCap (Joint Broker)

Geoff Nash / Alice Lane

 

Tel: +44 (0) 20 7220 0500

Numis Securities (Joint Broker)

James Black / Duncan Monteith

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Simon Conway / Ciara Martin

Tel: +44 (0) 20 3727 1000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Ian Johnson

2. Michael Roller

3. Jonathan Emms

2.

Reason for the notification

a.

Position/status

1. Executive Chairman

2. Chief Financial Officer

3. Chief Operating Officer

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Circassia Pharmaceuticals plc

b.

LEI

2138006YAT138TOGA556

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.08p each

 

 

GB00BJVD3B28

b.

Nature of the transaction

Purchase of Ordinary Shares

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1. 22.85p

2. 22.683p

3. 23.2p

1. 200,000

2. 200,000

3. 300,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2020-04-09

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGLGDSCDBDGGS
Date   Source Headline
22nd Jan 20154:40 pmRNSBlocklisting Interim Review
16th Jan 20152:13 pmRNSHolding(s) in Company
15th Jan 20155:27 pmRNSHolding(s) in Company
8th Jan 20157:00 amRNSCompletes Recruitment for Cat Allergy Phase III
31st Dec 20147:00 amRNSTotal Voting Rights
8th Dec 20147:00 amRNSResults from Ragweed Allergy Treatment Phase IIb
28th Nov 20143:46 pmRNSTotal Voting Rights
11th Nov 20147:00 amRNSInterim Management Statement
31st Oct 201412:35 pmRNSTotal Voting Rights
30th Sep 20141:28 pmRNSTotal Voting Rights
29th Aug 201412:20 pmRNSTotal Voting Rights
20th Aug 20143:36 pmRNSHolding(s) in Company
31st Jul 201411:27 amRNSTotal Voting Rights
29th Jul 20147:00 amRNSHalf Yearly Report
4th Jul 20141:07 pmRNSHolding(s) in Company
30th Jun 20141:08 pmRNSHolding(s) in Company
30th Jun 20141:04 pmRNSTotal Voting Rights
26th Jun 20144:41 pmRNSHolding(s) in Company
13th Jun 20147:00 amRNSCircassia Announces Results from Phase IIb Study
3rd Jun 201410:00 amRNSNotice of Results
30th May 20143:51 pmRNSTotal Voting Rights
23rd May 20145:58 pmRNSHolding(s) in Company
19th May 20147:00 amRNSInterim Management Statement
30th Apr 20145:39 pmRNSTotal Voting Rights
11th Apr 20145:35 pmRNSPartial Exercise of Over-allotment Option
11th Apr 20145:33 pmRNSEnd of Stabilisation Notice
1st Apr 20145:57 pmRNSHolding(s) in Company
31st Mar 20142:48 pmRNSTotal Voting Rights
31st Mar 20142:41 pmRNSHolding(s) in Company
27th Mar 20144:44 pmRNSDirector/PDMR Shareholding
20th Mar 20144:39 pmRNSHolding(s) in Company
19th Mar 20148:00 amRNSAdditional Listing
18th Mar 20144:53 pmRNSHolding(s) in Company
18th Mar 20144:46 pmRNSHolding(s) in Company
18th Mar 20144:37 pmRNSDirector/PDMR Shareholding
18th Mar 20141:35 pmRNSHolding(s) in Company
18th Mar 20148:00 amRNSAdmission to trading on the London Stock Exchange
14th Mar 20146:06 pmRNSHolding(s) in Company
13th Mar 20145:17 pmRNSPublication of Prospectus
13th Mar 20147:01 amRNSCircassia announces offer price
13th Mar 20147:01 amRNSStabilisation Notice
13th Mar 20147:00 amRNSOffer Price Set at 310 Pence per Ordinary Share
21st Sep 20065:04 pmRNSInterim Results
21st Sep 20065:03 pmRNSFinal Results
19th Jul 20068:43 amRNSChange of registered office
3rd Apr 20064:32 pmRNSStatement re. Suspension
3rd Apr 20067:01 amRNSSuspension - Capricorn Resour
20th Dec 20057:00 amRNSAGM Statement
16th Dec 20054:48 pmRNSAGM Statement
28th Sep 20053:17 pmRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.